|Day Low/High||5.49 / 5.82|
|52 Wk Low/High||4.95 / 18.25|
NEW YORK, June 8, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MiMedx Group, Inc.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MiMedx Group, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by management of MiMedx Group, Inc.
Glancy Prongay & Murray LLP ("GPM") announces that it has commenced an investigation on behalf of MiMedx Group, Inc.
Kaskela Law LLC announces that it has commenced an investigation of MiMedx Group, Inc.
MARIETTA, Ga., June 7, 2018 /PRNewswire/ -- MiMedx Group, Inc.
Company to Restate Financial Statements for Fiscal Years 2012 through 2016, and Interim Periods of 2017 Related to Revenue Recognition
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in MiMedx Group Inc , where a total of 13,930 contracts have traded so far, representing approximately 1.4 million underlying shares. That amounts to about 62.1% of MDXG's average daily trading volume over the past month of 2.2 million shares.
Investors in MiMedx Group Inc saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDXG options chain for the new July 20th contracts and identified one put and one call contract of particular interest.
Investors in MiMedx Group Inc saw new options begin trading this week, for the December 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
COMPANY ANNOUNCES ITS REVENUE GUIDANCE FOR SECOND QUARTER AND INCREASES FULL YEAR REVENUE GUIDANCE
ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until April 25, 2018 to file lead plaintiff applications in securities class action lawsuits against MiMedx Group Inc.
Breakfast Symposium to Underscore Statistically Significant Evidence of EpiFix® in Healing DFUs and VLUs
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
President Trump is creating a level of uncertainty that breeds selling. But Jim Cramer has your game plan for next week.
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2018 to file lead plaintiff applications in securities class action lawsuits against MiMedx Group Inc.
Initiation of Phase 2B Study Follows Quickly After FDA Grants RMAT Designation for Knee OA
The law firm of Spector, Roseman & Kodroff, P.C.
Patients Experienced Clinically Meaningful Reduction in Pain
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.